You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

92 search results for: symposium

Emerging Clinical Data in Children With Atopic Dermatitis- Q&As
expert video

Emerging Clinical Data in Children With Atopic Dermatitis- Q&As

Dermatology
Explore the WCD 2023 ADVENT symposium’s insights into current and emerging treatment strategies for managing pediatric atopic dermatitis.
View more
IL-4 and IL-13: Shared and Unique Roles in Atopic Dermatitis (AD) and Prurigo Nodularis (PN)
expert video

IL-4 and IL-13: Shared and Unique Roles in Atopic Dermatitis (AD) and Prurigo Nodularis (PN)

Dermatology
Highlights from the WCD 2023 ADVENT symposium, exploring the distinctions and shared elements of atopic dermatitis and prurigo nodularis.
View more
Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children
expert video

Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children

Dermatology
Explore WCD 2023 ADVENT symposium's insights into managing short and long-term challenges of pediatric atopic dermatitis.
View more
Practical Considerations for the Management of Children With Moderate-to-severe Atopic Dermatitis
expert video

Practical Considerations for the Management of Children With Moderate-to-severe Atopic Dermatitis

Dermatology
Highlights from the 2023 WCD ADVENT symposium, exploring practical considerations for the management of atopic dermatitis in children.
View more
Skin Barrier, Neuroimmune Axis, and Type 2 Inflammation in Atopic Dermatitis - Q&As
expert video

Skin Barrier, Neuroimmune Axis, and Type 2 Inflammation in Atopic Dermatitis - Q&As

Dermatology
Expert insights on the plasticity of inflammation, atopic dermatitis endotypes, and dysbiosis – Audience Q&A from the ADVENT symposium at ISID 2023.
View more
Role of Type 2 Inflammation in Chronic Inflammatory Diseases
expert video

Role of Type 2 Inflammation in Chronic Inflammatory Diseases

Dermatology
Type 2 inflammatory mechanisms and key type 2 cytokines in the pathogenesis of atopic dermatitis – Presentation from the ADVENT symposium at ISID 2023
View more
Targeting Type 2 Inflammation in Children with AD​
expert video

Targeting Type 2 Inflammation in Children with AD​

Dermatology
The impact of type 2 inflammation in itch and barrier dysfunction in atopic dermatitis – Presentation from the ADVENT symposium at EAACI 2023.
View more
The Disease Burden of AD in Children and the Impact of Type 2 Comorbidities 
expert video

The Disease Burden of AD in Children and the Impact of Type 2 Comorbidities 

Dermatology
Multidimensional disease burden of atopic dermatitis in children from a real-world case study – Presentation from the ADVENT symposium at EAACI 2023.
View more
Targeting Type 2 Inflammation in Children with Atopic Dermatitis: Opportunity for Early Intervention? - Q&As
expert video

Targeting Type 2 Inflammation in Children with Atopic Dermatitis: Opportunity for Early Intervention? - Q&As

Dermatology
Clinical trial and real-world data for targeted therapies for children with atopic dermatitis– Presentation from the ADVENT symposium at EAACI 2023.
View more
New Perspectives in Understanding the Pathophysiology of Atopic Dermatitis in Children
expert video

New Perspectives in Understanding the Pathophysiology of Atopic Dermatitis in Children

Dermatology
Highlights from the ADVENT WCD 2023 symposium delving into the pathophysiology and management of atopic dermatitis in children.
View more
The Association Between Epidermal Barrier Dysfunction and S. aureus Colonization in Atopic Dermatitis
expert video

The Association Between Epidermal Barrier Dysfunction and S. aureus Colonization in Atopic Dermatitis

Dermatology
Dr. Lisa Beck highlights the association between epidermal barrier dysfunction and S. aureus colonization in her talk at the ISDS 2023 ADVENT symposium.
View more
Type 2 Inflammation Modulates the Neuroimmune Axis in PN
expert video

Type 2 Inflammation Modulates the Neuroimmune Axis in PN

Dermatology
Highlights from the WCD 2023 ADVENT symposium, examining how type 2 inflammation influences the neuroimmune axis in prurigo nodularis.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: Czech RepublicChange country/region